Latest Healthcare It News

Page 2 of 142
Ramsay Santé has secured approval for a foreign exempt listing on the ASX, clearing a key operational hurdle for Ramsay Health Care’s proposed demerger. The transaction remains conditional on shareholder, Court and other approvals, with CDI trading provisionally scheduled to begin from 1 December.
Ada Torres
Ada Torres
12 Nov 2026
Alcidion has entered FY27 with record contracted revenue, a debt-free balance sheet and reaffirmed guidance for revenue and underlying EBITDA to exceed FY26. Shareholders also approved a 10-for-1 share consolidation as the healthcare software company weighs buy-backs, acquisitions and further platform investment.
Victor Sage
Victor Sage
12 Nov 2026
Nanosonics has secured a second US FDA 510(k) clearance for its CORIS System, expanding the range of colonoscopes and gastroscopes eligible for reprocessing. The regulatory milestone supports planned US launch activities, although the company has not disclosed a launch date or financial forecast.
Ada Torres
Ada Torres
11 Nov 2026
Promisia Healthcare has converted sustained occupancy above 95% into a 50% rise in underlying EBITDAF, positive free cash flow and its first interim dividend. The NZX-listed aged-care operator has also raised FY27 guidance to at least NZ$9 million, although Chatswood has lifted post-acquisition leverage.
Ada Torres
Ada Torres
11 Nov 2026
Third Age Health will acquire 75% of New Zealand asbestos specialist Consultex Group for $3.75 million, adding a new Testing, Inspection & Compliance vertical. The deal will be funded through existing cash and bank debt, with settlement expected by 30 November 2026.
Victor Sage
Victor Sage
6 Nov 2026
Con Edison delivered stronger third-quarter earnings and tightened its full-year adjusted EPS range, while positioning electrification and infrastructure spending as the next leg of growth. The picture is less clean beneath the headline, with year-to-date GAAP profit boosted by a Mountain Valley Pipeline sale and further equity issuance still ahead.
Maxwell Dee
Maxwell Dee
6 Nov 2026
Marlin Global’s portfolio fell 6.3% in FY2026 while its benchmark gained 30.5%, prompting a tighter risk framework and a broader portfolio. The NZX-listed investment company has started FY2027 more strongly, but the recovery remains early.
Victor Sage
Victor Sage
6 Nov 2026
Enero Group delivered stronger FY26 earnings and a $24.5 million net cash position, but its new financial year has opened with group EBITDA down 28% as Hotwire and BMF absorb restructuring and client losses. Orchard’s record quarter and rising AI revenue provide the counterweight, but execution remains the central test.
Victor Sage
Victor Sage
6 Nov 2026
Solventum has raised its full-year adjusted earnings forecast after a third quarter shaped by the expected reversal of ERP-related advance orders. The healthcare technology company also completed its major system cutovers and reported strong growth in Advanced Wound Care.
Ada Torres
Ada Torres
6 Nov 2026
Cardinal Health has lifted its fiscal 2027 earnings outlook after a strong opening quarter, with revenue reaching US$67.5 billion and non-GAAP diluted EPS rising 28%. The healthcare distributor also completed a US$500 million share repurchase and advanced several strategic initiatives.
Ada Torres
Ada Torres
5 Nov 2026
The Cigna Group raised its 2026 adjusted earnings outlook after third-quarter revenue rose 6%, while pharmacy benefit pressure kept underlying profit broadly flat. The health insurer also unveiled a US$3 billion modernisation and productivity programme targeting longer-term growth.
Ada Torres
Ada Torres
5 Nov 2026
STERIS delivered 9% second-quarter revenue growth and lifted its fiscal 2027 adjusted EPS outlook, helped partly by tariff refunds. Life Sciences led the operating gains, while weaker cash flow and a new restructuring plan add important qualifications.
Ada Torres
Ada Torres
5 Nov 2026

Browse the archive

Full archive